SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-20-000121
Filing Date
2020-05-12
Accepted
2020-05-12 11:23:50
Documents
26
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl0508form10q.htm 10-Q 169254
2 EXHIBIT 31.1 cncl0508form10qexh31_1.htm EX-31.1 8259
3 EXHIBIT 31.2 cncl0508form10qexh31_2.htm EX-31.2 8273
4 EXHIBIT 32.1 cncl0508form10qexh32_1.htm EX-32.1 4191
  Complete submission text file 0001554795-20-000121.txt   695470

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cncl-20200331.xml EX-101.INS 38421
6 XBRL SCHEMA FILE cncl-20200331.xsd EX-101.SCH 7952
7 XBRL CALCULATION FILE cncl-20200331_cal.xml EX-101.CAL 16962
8 XBRL DEFINITION FILE cncl-20200331_def.xml EX-101.DEF 9731
9 XBRL LABEL FILE cncl-20200331_lab.xml EX-101.LAB 73134
10 XBRL PRESENTATION FILE cncl-20200331_pre.xml EX-101.PRE 52902
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 20867630
SIC: 6770 Blank Checks